Caladrius Biosciences to Participate at the Upcoming May Conferences
07 mai 2019 08h30 HE
|
Caladrius Biosciences, Inc.
BASKING RIDGE, N.J., May 07, 2019 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a late-stage therapeutics development biopharmaceutical company...
Caladrius Biosciences to Host 2019 First Quarter Financial Results Conference Call on Thursday, May 9, 2019 at 4:30 p.m. Eastern Time
02 mai 2019 08h30 HE
|
Caladrius Biosciences, Inc.
BASKING RIDGE, N.J., May 02, 2019 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a late-stage therapeutics development biopharmaceutical company...
Caladrius Biosciences to Participate in Upcoming Conferences
03 avr. 2019 08h30 HE
|
Caladrius Biosciences, Inc.
BASKING RIDGE, N.J., April 03, 2019 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a late-stage therapeutics development biopharmaceutical company...
Caladrius Biosciences to Host 2018 Fourth Quarter and Year End Financial Results Conference Call on Thursday, March 14, 2019 at 4:30 p.m. Eastern Time
13 mars 2019 16h05 HE
|
Caladrius Biosciences, Inc.
BASKING RIDGE, N.J., March 13, 2019 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a late-stage therapeutics development biopharmaceutical company...
Caladrius Biosciences to Present at the Alliance for Regenerative Medicine 7th Annual Cell & Gene Therapy Investor Day
11 mars 2019 08h30 HE
|
Caladrius Biosciences, Inc.
BASKING RIDGE, N.J., March 11, 2019 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a late-stage therapeutics development biopharmaceutical company...
Caladrius Biosciences Reports Top-Line Data for the Phase 2a Sanford Project: T-Rex Trial of CLBS03 for Recent Onset Type 1 Diabetes
13 févr. 2019 17h26 HE
|
Caladrius Biosciences, Inc.
BASKING RIDGE, N.J., Feb. 13, 2019 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a late-stage therapeutics development biopharmaceutical company with...
Caladrius Biosciences to Present at Upcoming February Conferences
05 févr. 2019 08h00 HE
|
Caladrius Biosciences, Inc.
BASKING RIDGE, N.J., Feb. 05, 2019 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a late-stage therapeutics development biopharmaceutical company with...
Caladrius Biosciences to Participate in Upcoming January Conferences
07 janv. 2019 08h00 HE
|
Caladrius Biosciences, Inc.
Basking Ridge, New Jersey, Jan. 07, 2019 (GLOBE NEWSWIRE) -- Caladrius Biosciences to Participate in Upcoming January Conferences BASKING RIDGE, N.J. (January 7, 2019) – Caladrius Biosciences, Inc....
Caladrius Biosciences to Participate in the Inv€$tival Showcase in Partnership with Jefferies and the Jefferies 2018 London Healthcare Conference
09 nov. 2018 08h30 HE
|
Caladrius Biosciences, Inc.
Basking Ridge, NJ, Nov. 09, 2018 (GLOBE NEWSWIRE) -- Caladrius Biosciences to Participate in the Inv€$tival Showcase in Partnership with Jefferies and the Jefferies 2018 London Healthcare Conference...
Caladrius Biosciences Reports 2018 Third Quarter Financial Results
08 nov. 2018 16h05 HE
|
Caladrius Biosciences, Inc.
Development programs remain on track accompanied by continued strong fiscal management Conference call begins today at 4:30 p.m. Eastern time BASKING RIDGE, N.J., Nov. 08, 2018 (GLOBE NEWSWIRE) --...